Canton Strategic Holdings (CNTN) Long-Term Debt Issuances (2021 - 2025)

Canton Strategic Holdings (CNTN) posted Long-Term Debt Issuances of $68501.0 for Q4 2025, down 22.68% on a QoQ basis from $88599.0 in Q3 2025.

Canton Strategic Holdings (CNTN) Long-Term Debt Issuances (2021 - 2025) Analysis & Trends

Canton Strategic Holdings' Long-Term Debt Issuances history runs 3 years deep, the most recent figure standing at $68501.0 for Q4 2025.

Quarterly Long-Term Debt Issuances changed N/A year-over-year to $68501.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $221869.0 (changed N/A YoY) and the FY2025 annual result came in at $221869.0, changed N/A from the prior year.
Long-Term Debt Issuances was $68501.0 for Q4 2025 at Canton Strategic Holdings, down from $88599.0 in the prior quarter.
Across five years, Long-Term Debt Issuances topped out at $379989.0 in Q2 2021 and bottomed at -$14645.0 in Q3 2022.
A 3-year average of $130866.3 and a median of $68501.0 in 2025 frame the typical range for Long-Term Debt Issuances.
Peak annual rise in Long-Term Debt Issuances reached 56.77% in 2022, while the deepest fall reached 104.37% in 2022.
Canton Strategic Holdings' Long-Term Debt Issuances stood at $40001.0 in 2021, then plunged by 63.39% to $14645.0 in 2022, then soared by 367.74% to $68501.0 in 2025.
Business Quant data shows CNTN's Long-Term Debt Issuances at $68501.0 in Q4 2025, $88599.0 in Q3 2025, and $21738.0 in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Long-Term Debt Issuances (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	-
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	-
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Canton Strategic Holdings	427.87 Mn	427.87 Mn	-	-

Download Data